World's Best Scientists 2026 revealed!
Lawrence H. Einhorn

Lawrence H. Einhorn

D-Index & Metrics

Medicine

D-Index
134
Citations
65415
World Ranking
2154
National Ranking
1216

Research.com Recognitions

  • 2001 - Member of the National Academy of Sciences
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Lawrence H. Einhorn is primarily affiliated with Indiana University in the United States. Their research career has focused extensively on medicine, with a particular emphasis on surgery, pulmonary and respiratory medicine, neurology, oncology, and genetics.

Their main topics of study include testicular diseases and treatments, sarcoma diagnosis and treatment, neuroblastoma research and treatments, urologic and reproductive health conditions, glioma diagnosis and treatment, cancer treatment and pharmacology, and cancer genomics and diagnostics.

They have contributed to a significant number of publications, particularly in the following venues:

  • Journal of Clinical Oncology (60 publications)
  • The Journal of Urology (9 publications)
  • Cancer Medicine (4 publications)
  • UNC Libraries (4 publications)
  • Cancer Research (3 publications)

Among their recent published papers are:

  • "Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153" (2020, Journal of Clinical Oncology)
  • "Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy" (2023, Journal of Clinical Oncology)
  • "Integrated Expression of Circulating miR375 and miR371 to Identify Teratoma and Active Germ Cell Malignancy Components in Malignant Germ Cell Tumors" (2020, European Urology)
  • "A phase II study assessing the safety and efficacy of ASP1650 in male patients with relapsed refractory germ cell tumors" (2022, Investigational New Drugs)
  • "Testicular Cancer: Biology to Bedside" (2021, Cancer Research)

Frequent coauthors in their work include:

  • Nabil Adra
  • Nasser H. Hanna
  • Sandra K. Althouse
  • Clint Cary
  • Timothy A. Masterson

Lawrence H. Einhorn has been recognized by their peers through membership in notable scientific organizations, specifically as a member of the National Academy of Sciences since 2001 and as a member of the Association of American Physicians.

Best Publications

  • Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy

    Nasser Hanna;Frances A. Shepherd;Frank V. Fossella;Jose R. Pereira

  • Cis-diamminedichloroplatinum, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer

    Lawrence H. Einhorn;John Donohue

  • Treatment of Disseminated Germ-Cell Tumors with Cisplatin, Bleomycin, and either Vinblastine or Etoposide

    S D Williams;S D Williams;R Birch;R Birch;L H Einhorn;L Irwin;L Irwin

  • A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

    P J Loehrer;L H Einhorn;P J Elson;E D Crawford

  • Drugs five years later. Cisplatin.

    Patrick Loehrer;Lawrence Einhorn

  • Recommendations on the Use of 18F-FDG PET in Oncology

    James W. Fletcher;James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

  • Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

    Alan B. Sandler;J. Nemunaitis;C. Denham;J. Von Pawel

  • Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

    Paul B. Chapman;Lawrence H. Einhorn;Michael L. Meyers;Scott Saxman

  • Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

    F. Roila;J. Herrstedt;M. Aapro;R. J. Gralla

  • Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

    Janice L. Gabrilove;Charles S. Cleeland;Robert B. Livingston;Brenda Sarokhan

  • Randomized Phase III Trial Comparing Irinotecan/Cisplatin With Etoposide/Cisplatin in Patients With Previously Untreated Extensive-Stage Disease Small-Cell Lung Cancer

    Nasser Hanna;Paul A. Bunn;Corey Langer;Lawrence Einhorn

  • A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

    C Jacobs;G Lyman;E Velez-García;K S Sridhar

  • Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group

    B J Roth;D H Johnson;L H Einhorn;L P Schacter

  • Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study.

    S B Saxman;K J Propert;L H Einhorn;E D Crawford

  • Treatment of testicular cancer: a new and improved model.

    L H Einhorn

  • Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology

    Nasser Hanna;Marcus Neubauer;Constantin Yiannoutsos;Ronald McGarry

  • Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

    Carsten Bokemeyer;Craig R. Nichols;Jean P. Droz;Hans J. Schmoll

  • High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

    Lawrence H. Einhorn;Stephen D. Williams;Amy Chamness;Mary J. Brames

  • Recommendations on the Use of 18 F-FDG PET in Oncology

    James W. Fletcher;Benjamin Djulbegovic;Heloisa P. Soares;Barry A. Siegel

  • Phase I II M ulticenter R andomized T rial o f t he D artmouth Regimen V ersus D acarbazine i n P atients With M etastatic M elanoma

    Paul B. Chapman;Lawrence H. Einhorn;Michael L. Meyers;Scott Saxman

Frequent Co-Authors

Patrick J. Loehrer
Patrick J. Loehrer Indiana University
Sophie D. Fosså
Sophie D. Fosså Oslo University Hospital
Robert Huddart
Robert Huddart Institute of Cancer Research
Howard D. Sesso
Howard D. Sesso Harvard Medical School
M. Eileen Dolan
M. Eileen Dolan University of Chicago
Christian Kollmannsberger
Christian Kollmannsberger University of British Columbia
Thomas M. Ulbright
Thomas M. Ulbright Indiana University
Christopher Sweeney
Christopher Sweeney Harvard University
David H. Johnson
David H. Johnson The University of Texas Southwestern Medical Center
Eric R. Gamazon
Eric R. Gamazon Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical education in the USA opens doors to a variety of online degrees and career pathways. For those interested in healthcare management, pursuing one of the best online mha programs can prepare you for leadership roles in hospitals and health systems, offering flexibility for working professionals.

Registered nurses looking to advance their qualifications without traditional in-person clinicals can consider an rn to bsn online with no clinicals program. These programs are tailored to help RNs earn a bachelor's degree efficiently while balancing work and personal responsibilities.

For nurses aspiring to the very top of clinical practice, there are options for both accelerated and more flexible doctoral programs. Those seeking quick advancement can look for some of the shortest dnp programs online, which enable completion in an expedited timeframe. Alternatively, applicants needing a manageable workload may explore the easiest dnp programs to find courses designed for accessibility and work-life balance.

Whether your goal is to move into management, advance your nursing credentials, or specialize at the doctoral level, there are tailored online pathways to fit your needs and career aspirations.

Best Scientists Citing Lawrence H. Einhorn

Trending Scientists